# OnCo record firstmappp (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/firstmappp/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "firstmappp", "NCT01371201" ;
  schema:name "FIRSTMAPPP"@en ;
  schema:alternateName "First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma"@en, "IGR2010/1715"@en ;
  schema:description "FIRSTMAPPP was the first randomised trial ever completed in metastatic phaeochromocytoma and paraganglioma, rare hormone-producing tumours; the kinase inhibitor sunitinib kept 36 percent of patients free of progression at a year against 19 percent on placebo, giving the disease its first drug with randomised evidence."@en ;
  schema:url <https://onco.cc/trials/firstmappp/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01371201> ;
  onco:status "positive" ;
  onco:tag "soc-trials" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/metastatic-ppgl/>, <https://onco.cc/cancers/pheochromocytoma-paraganglioma/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:drugs <https://onco.cc/drugs/sunitinib/> ;
  onco:institutions <https://onco.cc/institutions/gustave-roussy/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-firstmappp-sunitinib-metastatic-ppgl-baudin-lancet-2024/> .